Effects of Vocal Exercises for Spasmodic Dysphonia
NCT03349086 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2019-05-23
Summary
The purpose of this study is to assess the effect of voice exercise and voice rest on subject's perception of vocal handicap and communicative participation following Botox injections for adductor spasmodic dysphonia.
Conditions
- Adductor Spasmodic Dysphonia
Interventions
- BEHAVIORAL
-
Voice Exercise
Voice exercise will consist of sustained pitches and pitch glides on a variety of different vocal facilitators.
Sponsors & Collaborators
-
University of Wisconsin, Madison
lead OTHER
Principal Investigators
-
Brienne Ruel, MS · University of Wisconsin, Madison
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-07-28
- Primary Completion
- 2018-07-25
- Completion
- 2018-07-25
Countries
- United States
Study Locations
More Related Trials
-
Spasmodic Dysphonia Interviews
NCT06561334 ·Status: ACTIVE_NOT_RECRUITING
-
Botulinum Toxin Injection in the UES for R-CPD
NCT06356025 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia
NCT05158166 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 2 Trial of Deep Brain Stimulation for Spasmodic Dysphonia
NCT04938154 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
INNOVATIVE TREATMENT OF SCARRED VOCAL FOLDS BY LOCAL INJECTION OF AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION: EFFICACY VERSUS PLACEBO
NCT05385159 ·Status: UNKNOWN ·Phase: PHASE2
-
Cricopharyngeal Dysfunction in Adults
NCT03598933 ·Status: UNKNOWN
-
Essential Voice Tremor: A Study of Botulinum Toxin Treatment and Injection Augmentation
NCT02711995 ·Status: COMPLETED ·Phase: NA
-
Reversal of Botulinum Neurotoxin Injection Related Dysphonia With Pyridostigmine
NCT05110417 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia
NCT00432341 ·Status: TERMINATED ·Phase: PHASE4
-
Does ESWT With BoNTA Treatment Improve Outcomes When Compared to Standard Management for Upper Limb Spasticity Patient.
NCT05226637 ·Status: RECRUITING ·Phase: NA
-
Botox for the Treatment of Chronic Exertional Compartment Syndrome
NCT03922139 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity
NCT01387074 ·Status: COMPLETED
-
Thalamic Deep Brain Stimulation for Spasmodic Dysphonia- DEBUSSY Trial
NCT02558634 ·Status: COMPLETED ·Phase: NA
-
The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity
NCT05889026 ·Status: COMPLETED ·Phase: NA
-
BOTOX® Treatment in Adult Patients With Post-Stroke Lower Limb Spasticity
NCT01575054 ·Status: COMPLETED ·Phase: PHASE3
-
Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain
NCT00178945 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
NCT00564681 ·Status: COMPLETED ·Phase: PHASE2
-
Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity
NCT00234546 ·Status: COMPLETED ·Phase: PHASE4
-
Ultrasound-guided Botulinum Toxin Injection on Cricopharyngeal Muscle Dysfunction
NCT06328556 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Botulinum Toxin Injection Efficiency
NCT01041157 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function
NCT00076687 ·Status: COMPLETED ·Phase: PHASE2
-
Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)
NCT01390922 ·Status: COMPLETED
-
Targeting Methods of Botulinum Toxin Injections for Cervical Dystonia
NCT03946046 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.
NCT05224349 ·Status: COMPLETED
-
Botulinum Toxin Type A Injection Into the Gastrocnemius Muscle for Treatment of Nocturnal Calf Cramps in Patients With Lumbar Spinal Stenosis
NCT02444351 ·Status: COMPLETED ·Phase: NA